<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-07-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
        </entity>
        <period>
            <startDate>2025-07-23</startDate>
            <endDate>2025-07-23</endDate>
        </period>
    </context>
    <context id="From2025-07-232025-07-23_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130166</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-23</startDate>
            <endDate>2025-07-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-07-23" id="Fact000003">0001130166</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="AsOf2025-07-23" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2025-07-232025-07-23_1"
      id="xdx2ixbrl0016"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ffd:SubmissnTp contextRef="AsOf2025-07-23" id="Fact000010">S-4</ffd:SubmissnTp>
    <ffd:FormTp contextRef="AsOf2025-07-23" id="Fact000011">S-4</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-07-23" id="Fact000012">Cyclacel Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="From2025-07-232025-07-23_1" id="Fact000013">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2025-07-232025-07-23_1" id="Fact000014">Class A common stock, par value $0.00001 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-07-232025-07-23_1" id="Fact000024">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="From2025-07-232025-07-23_1"
      decimals="INF"
      id="Fact000015"
      unitRef="Shares">1118282</ffd:AmtSctiesRegd>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-07-232025-07-23_1"
      decimals="INF"
      id="Fact000017"
      unitRef="USD">2578304</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="From2025-07-232025-07-23_1"
      decimals="INF"
      id="Fact000018"
      unitRef="Ratio">0.00015310</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="From2025-07-232025-07-23_1"
      decimals="INF"
      id="Fact000019"
      unitRef="USD">394.74</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2025-07-23"
      decimals="0"
      id="Fact000025"
      unitRef="USD">2578304</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2025-07-23"
      decimals="INF"
      id="Fact000026"
      unitRef="USD">394.74</ffd:TtlFeeAmt>
    <ffd:PrevslyPdFlg contextRef="From2025-07-232025-07-23_1" id="Fact000027">false</ffd:PrevslyPdFlg>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2025-07-23"
      decimals="0"
      id="Fact000028"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2025-07-23"
      decimals="0"
      id="Fact000029"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2025-07-23"
      decimals="INF"
      id="Fact000030"
      unitRef="USD">394.74</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-07-232025-07-23_1" id="Fact000033">Represents the maximum number of shares of Common Stock, par value $0.001 per share (&#x201c;Cyclacel Common Stock&#x201d;),
of Cyclacel Pharmaceuticals, Inc. (the &#x201c;Registrant&#x201d;), issuable to securityholders of Fitters Sdn. Bhd. (&#x201c;Fitters&#x201d;)
pursuant to the Exchange and related transactions contemplated by the Exchange Agreement, dated as of May 6, 2025, as amended on July
7, 2025, by and among the Registrant, FITTERS Diversified Berhad and Fitters.Estimated solely for the purpose of calculating the registration fee under Rule 457(f)(2)
under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). As Fitters is a private company, there is no market
for its securities, therefore, the proposed maximum aggregate offering price per share was calculated based on the book value as of July
10, 2025 of the Fitters Ordinary Shares that will be exchanged in the Transaction, which amount equals $2,578,304.The registration fee is determined in accordance with Section 6(b) of the
Securities Act and calculated by multiplying the estimated aggregate offering price of securities to be registered by 0.00015310.</ffd:OfferingNote>
</xbrl>
